Close

AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat Presbyopia

Go back to AbbVie's (ABBV) Allergan Submits NDA to FDA for AGN-190584 to Treat Presbyopia
AbbVie (NYSE: ABBV) Delayed: 166.41 +1.75 (1.06%)
Previous Close $164.66    52 Week High $68.12 
Open $165.02    52 Week Low $50.71 
Day High $166.60    P/E 36.10 
Day Low $163.25    EPS $4.61 
Volume 5,532,362